ロード中...
Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis
Development of an improved tuberculosis (TB) vaccine is a high worldwide public health priority. Bacillus Calmette-Guerin (BCG), the only licensed TB vaccine, provides variable efficacy against adult pulmonary TB, but why this protection varies is unclear. Humans are regularly exposed to non-tubercu...
保存先:
| 出版年: | J Infect Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736075/ https://ncbi.nlm.nih.gov/pubmed/31165861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz285 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|